d33ply - AI Investigative Podcast

d33ply
  • 0.0 (0)
  • Daily News
  • Updated Biweekly

AI-powered investigative journalism. Deep analysis of trending topics across technology, science, politics, and culture. This feed features select free episodes. Get daily episodes across 14 topics at d33ply.xyz

Episodes

  1. Feb 13

    Cursor's 30,000-engineer claim and Nvidia's telling silence

    A two-year-old startup valued at $9.9 billion claims nearly every Nvidia engineer uses its AI code editor. Nvidia has said nothing to confirm it. The episode examines what unverifiable marketing claims reveal about the AI coding tool gold rush and the fragile economics of developer tooling. More episodes at d33ply.xyz

    20 min

  2. Feb 12

    Forbes and the mogul myth: 20 interviews, 100 years, zero hard questions

    From Henry Ford in 1928 to Elon Musk in 2003, Forbes has offered America's wealthiest entrepreneurs a platform to craft origin myths unchallenged. An examination of how access journalism doubles as a credentialing machine — and who absorbs the cost. More episodes at d33ply.xyz

    20 min

  3. Feb 11

    Bitso's $12B secret: most of it is remittances, not trading

    Bitso has processed over $12B in transactions across Latin America, but the bulk of its volume comes from cross-border remittances and currency hedging — not speculation. An examination of how a Mexico City crypto exchange became financial infrastructure for a region where 57% of adults lack bank accounts, and whether that parallel system can hold. More episodes at d33ply.xyz

    20 min

  4. Feb 11

    OpenAI's conscience was a nonprofit. Now it's a Pentagon contractor.

    Between 2023 and 2025, OpenAI deleted its weapons prohibition, appointed a former NSA director to its board, and deployed ChatGPT on classified military networks. The trajectory from AI safety nonprofit to defense partner traces a $40 billion incentive structure that made each step feel inevitable. More episodes at d33ply.xyz

    20 min

  5. Feb 10

    Artemis and the case for the Moon as Mars rehearsal

    NASA's Artemis program frames the Moon not as a rival destination to Mars but as a prerequisite — a proving ground three days from Earth where life-support failures remain survivable. The logic rests on physics, biology, and resource engineering that Mars-first advocates tend to underestimate. More episodes at d33ply.xyz

    20 min

  6. Feb 8

    Manchester's ex-criminal hackers are coming for your 12-year-olds

    A programme run by former convicted hackers is recruiting secondary school students in Manchester, redirecting young technical talent toward cybersecurity careers before the criminal justice system intervenes. With 3.5 million unfilled cybersecurity positions projected by 2026, the initiative tests a discomforting premise: the skills that produce elite defenders and dangerous criminals are identical. More episodes at d33ply.xyz

    20 min

  7. Feb 4

    André Ricciardi is dying. A24 is betting his comedy about it will sell.

    A terminally ill man's cancer documentary won two Sundance 2025 awards and earned a 92% on Rotten Tomatoes. With A24 and Sandbox Films backing a theatrical release, the film tests whether dark humor can work as both art and public health message. More episodes at d33ply.xyz

    20 min

  8. Feb 3

    The NHS bet £150M that one blood test can catch 50 cancers early

    A multi-cancer early detection test backed by £150 million in NHS funding is nearing its first large-scale results from 140,000 participants. The trial could reshape screening for dozens of cancers that currently go undetected until late stages — or expose the limits of liquid biopsy technology. More episodes at d33ply.xyz

    20 min

  9. Feb 1

    Medicare now demands proof that therapy works, and a $400B industry isn't ready

    New 2026 Medicare reimbursement rules tie behavioral health payments to demonstrated patient outcomes for the first time. After decades of intuition-driven practice, therapists and telehealth startups face a measurement-based care mandate that could reshape how mental health treatment is delivered and funded. More episodes at d33ply.xyz

    20 min

  10. Jan 28

    Boston Scientific's $14.5B bet on the blood clot vacuum

    Boston Scientific is paying ten times revenue to acquire Penumbra, a maker of mechanical thrombectomy devices used in 180,000 procedures last year. The deal signals that independent medtech companies face a scaling ceiling — and that the era of consolidation in life-saving hardware has arrived. More episodes at d33ply.xyz

    20 min
  • 10 Episodes

About

AI-powered investigative journalism. Deep analysis of trending topics across technology, science, politics, and culture. This feed features select free episodes. Get daily episodes across 14 topics at d33ply.xyz

Information